The Signatera assay showed positive correlations between ctDNA presence and cancer recurrence, suggesting its potential for ...

The number and frequency of intravesical instillations for non-muscle-invasive bladder cancer (NMIBC) impairs quality of life and needs to be reported in clinical trials.

With durable responses, encouraging survival outcomes, and evidence that some patients may become eligible for ...